I completely agre with Fouremm. I may add that at the Analyst Day, they mentioned that none of the 20 key opinion leaders had heard about RVX-208, but 100% were interested in being investigators in the BETonMACE trial.

Today's article in PlosOne (http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0151329#pone.0151329.ref047) and particularly the related comment (http://www.bu.edu/news/2016/03/23/new-proteins-discovered-that-link-obesity-driven-diabetes-to-cancer/) illustrate this point quite well - there is no mentioning of RVX-208???

BR

BKC